Aim of this study was to investigate the reliability and validity of 2D linear measures of ventricular enlargement as indirect markers of brain atrophy and possible predictors of clinical disability. In this retrospective longitudinal analysis of relapsing-remitting MS patients, brain volumes were computed at baseline and after 2 years. Frontal horn width (FHW), intercaudate distance (ICD), third ventricle width (TVW), and 4th ventricle width were obtained. Two-dimensional measures associated with brain volume at correlation analyses were entered in linear and logistic regression models testing the relationship with baseline clinical disability and 10-year confirmed disability progression (CDP), respectively. Possible cutoff values for clin...
Objective: To examine the predictive value of central atrophy in early multiple sclerosis (MS) patie...
The aim of this study was to investigate if brain atrophy in multiple sclerosis (MS) patients during...
BACKGROUND AND PURPOSE: MRI markers of neuroaxonal damage in MS have emerged as critical long-term p...
Aim of this study was to investigate the reliability and validity of 2D linear measures of ventricul...
Linear measures of cerebral ventricular enlargement may act as surrogate measures of cerebral atroph...
Introduction: Multiple sclerosis (MS) is a common neurological disease causing intermittent or cumul...
Methodological challenges limit the use of brain atrophy and lesion burden measures in the follow-up...
Background: Methodological challenges limit the use of brain atrophy and lesion burden measures in t...
Background: A percent brain volume change (PBVC) cut-off of −0.4% per year has been proposed to dist...
Objective: To determine 30-year brain atrophy rates following clinically isolated syndromes and the ...
Background: In multiple sclerosis (MS), brain atrophy depicted by magnetic resonance imaging reflect...
The third ventricle width (3VW) is an easily calculated measure of brain atrophy. The aim of this st...
Objective To determine whether brain atrophy and lesion volumes predict subsequent 10 year clinical ...
Background: Baseline brain volume (BV) is predictive at a group level but is difficult to interpret ...
BACKGROUND AND PURPOSE: Cerebral atrophy has been suggested to be a reliable magnetic resonance imag...
Objective: To examine the predictive value of central atrophy in early multiple sclerosis (MS) patie...
The aim of this study was to investigate if brain atrophy in multiple sclerosis (MS) patients during...
BACKGROUND AND PURPOSE: MRI markers of neuroaxonal damage in MS have emerged as critical long-term p...
Aim of this study was to investigate the reliability and validity of 2D linear measures of ventricul...
Linear measures of cerebral ventricular enlargement may act as surrogate measures of cerebral atroph...
Introduction: Multiple sclerosis (MS) is a common neurological disease causing intermittent or cumul...
Methodological challenges limit the use of brain atrophy and lesion burden measures in the follow-up...
Background: Methodological challenges limit the use of brain atrophy and lesion burden measures in t...
Background: A percent brain volume change (PBVC) cut-off of −0.4% per year has been proposed to dist...
Objective: To determine 30-year brain atrophy rates following clinically isolated syndromes and the ...
Background: In multiple sclerosis (MS), brain atrophy depicted by magnetic resonance imaging reflect...
The third ventricle width (3VW) is an easily calculated measure of brain atrophy. The aim of this st...
Objective To determine whether brain atrophy and lesion volumes predict subsequent 10 year clinical ...
Background: Baseline brain volume (BV) is predictive at a group level but is difficult to interpret ...
BACKGROUND AND PURPOSE: Cerebral atrophy has been suggested to be a reliable magnetic resonance imag...
Objective: To examine the predictive value of central atrophy in early multiple sclerosis (MS) patie...
The aim of this study was to investigate if brain atrophy in multiple sclerosis (MS) patients during...
BACKGROUND AND PURPOSE: MRI markers of neuroaxonal damage in MS have emerged as critical long-term p...